TAKE · NSE
TAKE Limited
₹15.86
+0.13% (+₹0.02)
Prev. close
₹15.84
Volume
2,71,857
Delivery %
87.4%
As of
23 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About TAKE Limited
TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and supply chain industries in India. The company offers intelligent platforms across life sciences, clinical research, biotechnology, and preventive healthcare. It also provides collaboration platform services, including subscription based software, implementation and configuration, maintenance and support, and other professional services. The company was formerly known as TAKE Solutions Limited and change its name to TAKE LIMITED in June 2026. TAKE LIMITED was incorporated in 2000 and is based in Chennai, India.
Details
Sector
Healthcare
Industry
Health Information Services
CEO
Ms. Vandana Gupta
Headquarters
Chennai
Employees
5
Website
takelimited.comExchange
View on NSE ↗Key stats
Market cap
₹231.33 Cr
P/E ratio (TTM)
37.7
EPS (TTM)
₹0.42
Beta (1Y · daily vs NIFTY 50)
0.38
Beta (5Y · monthly vs NIFTY 50)
1.58
Shares float
7.52 Cr
EPS · quarter ended Jun 2026
₹0.07
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (consolidated), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based
05 · Capital Structure & Asset Utilization
Debt/equity omitted where reported equity was zero or negative. Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
07 · Debt Level & Coverage
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹774.01 Cr | ₹655.19 Cr | ₹189.07 Cr | ₹3.60 Cr | ₹0 | ₹54.19 Cr | |
| EBITDA | ₹-286.11 Cr | ₹23.84 Cr | ₹-20.98 Cr | ₹-52.22 Cr | ₹2.74 Cr | ₹4.77 Cr |
| ₹-450.07 Cr | ₹-782.25 Cr | ₹-100.26 Cr | ₹-119.62 Cr | ₹37.47 Cr | ₹10.85 Cr | |
| Diluted EPS | ₹-30.91 | ₹-53.5 | ₹-6.86 | ₹-8.18 | ₹2.53 | ₹0.74 |
Depreciation & amortisation has filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹1,844.59 Cr | ₹1,223.10 Cr | ₹224.38 Cr | ₹88.11 Cr | ₹36.48 Cr | ₹36.24 Cr | |
| — | — | ₹46.37 Cr | ₹37.09 Cr | ₹0 | ₹0 | |
| Stockholders' equity | ₹1,124.69 Cr | ₹181.04 Cr | ₹108.60 Cr | ₹-8.87 Cr | ₹20.53 Cr | ₹31.00 Cr |
Current assets, Non-current assets, Fixed assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹135.24 Cr | ₹29.62 Cr | ₹20.02 Cr | ₹9.32 Cr | ₹-16.37 Cr | ₹-4.13 Cr | |
| Investing cash flow | ₹-56.99 Cr | ₹-30.64 Cr | ₹-2.13 Cr | ₹-7.46 Cr | ₹22.21 Cr | ₹1.74 Cr |
| ₹-83.95 Cr | ₹-54.51 Cr | ₹-35.72 Cr | ₹-11.74 Cr | ₹-3.24 Cr | ₹-72.36 L | |
| Capital expenditure | ₹-3.16 Cr | ₹-31.21 Cr | ₹-32.40 Cr | ₹-7.92 Cr | — | — |
| End cash position | ₹38.97 Cr | ₹29.00 Cr | ₹10.72 Cr | ₹84.50 L | ₹3.37 Cr | ₹25.96 L |
Depreciation & amortization, Capital expenditure have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21–Mar 25(15Q) | Jun 25 | Sep 25 | Dec 25–Jun 26(3Q) |
|---|---|---|---|---|
| Promoter | 53.41% | 53.34% | 5.19% | 0.00% |
| Public | 46.59% | 46.66% | 94.81% | 100.00% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.48 L Cr | ₹9,624 | 84.9 | 14.81 | 15.3% | 0.00 | +12.3% | +59.0% |
| Torrent Pharmaceuticals Limited | ₹1.88 L Cr | ₹4,985 | 78.8 | 22.38 | 25.8% | 1.79 | +21.5% | +36.5% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.20 L Cr | ₹686.7 | 181.0 | 13.70 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,170.1 | 25.9 | 4.28 | 18.6% | 0.46 | +18.4% | +12.0% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,034 | 99.7 | 20.52 | 16.8% | 0.48 | +22.0% | +123.5% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Dr. Reddy's Laboratories Limited | ₹1.01 L Cr | ₹1,211.2 | 30.5 | 2.68 | 11.4% | 0.21 | +3.2% | -7.4% |
| Manipal Health Enterprises Limited | ₹99,126.82 Cr | ₹760.95 | 150.7 | 11.76 | 7.8% | 1.53 | +18.0% | — |
| TAKE Limited | ₹231.33 Cr | ₹15.86 | 37.7 | 7.46 | 35.0% | 0.00 | — | +52.9% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 20
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.